[Extracoporeal irradiation of blood in the treatment of leukemia. Experiences on 25 patients with chronic lymphadenosis].
Extracorporeal irradiation of the blood (ECIB) is a valuable addition to the treatment of chronic lymphatic leukemia (CLL). Possibly the prognosis of chronic lymphatic leukemia can be significantly influenced by early treatment. In acute leukemia the increase of bone marrow proliferation can be useful in cases resistent to chemotherapy. Side effects of ECIB have not been observed.
D005112:Extracorporeal Circulation; D006801:Humans; D007945:Leukemia, Lymphoid / Q000532:radiotherapy*; D007951:Leukemia, Myeloid / Q000532:radiotherapy; D015470:Leukemia, Myeloid, Acute / Q000532:radiotherapy; D008213:Lymphocyte Activation / Q000528:radiation effects; D008722:Methods; D011879:Radiotherapy Dosage
Die extrakorporale Blutbestrahlung in der Leukämie-Behandlung. Erfahrungen an 25 Patienten mit chronischer Lymphadenose.